Interpretation and Optimization of Nutrition in the Intensive Care Units
IONIC
2 other identifiers
interventional
144
1 country
1
Brief Summary
Despite recommendations, inadequate nutritional intake in intensive care unit (ICU) patients remains frequent and can lead to complications such as infections, increased length of stay, prolonged weaning from ventilation, increased long-term mortality, and decreased quality of life after intensive care. Studies have shown that patients only receive up to 50-60% of prescribed calories and proteins due to many factors leading to nutritional support interruptions such as ICU procedures, physical therapy, transport for imaging or invasive procedures outside the ICU, and nutrition intolerance. Furthermore, this discrepancy between prescribed and delivered nutrition may go largely unnoticed, due to issues concerning inadequate manual or automated monitoring of delivered nutrition. A joint "Call to Action" by ASPEN, the Academy of Nutrition and Dietetics, and the American Society of Health-System Pharmacists stated that parenteral nutrition errors and their contributing factors could be prevented by improving the functionality of in-house Clinical Decision Support Systems and the interfaces between electronic health records (EHRs), automated preparation devices and pharmacy systems. Nutrow® is a software package designed to support nutritional management based on the calculation of recommended calorie and protein requirements, real-time calculation and monitoring of calorie and protein prescriptions, real-time calculation and monitoring of calories and protein truly delivered to patients, and information feedback to prescribers. Feedim® is a Medical Device Data System (MDDS), designed by Dim3, which transmits information from enteral feeding pumps to third-party software, such as Nutrow®. The aim of the study is to assess whether the joint use of Nutrow-Feedim improves the achievement of nutritional objectives in ICU patients prior to oral intake by reducing the discrepancy between prescribed and delivered calories and protein.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Apr 2024
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
March 26, 2024
CompletedFirst Posted
Study publicly available on registry
April 2, 2024
CompletedStudy Start
First participant enrolled
April 10, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 1, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
September 1, 2025
CompletedAugust 12, 2024
August 1, 2024
12 months
March 26, 2024
August 9, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Mean total daily calories delivered/prescribed ratio (percent)
Total (enteral+parenteral) prescribed and delivered calories are measured daily (kcal/day). The ratio of mean total daily delivered calories over the study period divided by the mean total daily prescribed calories over the study period will be calculated and expressed as a %
From ICU Day 3 to Day 28 or until any of the following if before day 28: Return to oral intake Discharge from the ICU Death
Secondary Outcomes (9)
Mean total daily protein delivered/prescribed ratio (%)
From ICU Day 3 to Day 28 or until any of the following if before day 28: Return to oral intake Discharge from the ICU Death
Mean total daily calories delivered/recommended ratio (percent)
From ICU Day 3 to Day 28 or until any of the following if before day 28: Return to oral intake Discharge from the ICU Death
Mean total daily protein delivered/recommended ratio (percent)
From ICU Day 3 to Day 28 or until any of the following if before day 28: Return to oral intake Discharge from the ICU Death
Nutritional support duration (days)
From ICU Day 3 to Day 28 or until any of the following if before day 28: Return to oral intake Discharge from the ICU Death
Time to initiation of nutritional support (days)
From ICU Day 3 to Day 28 or until any of the following if before day 28: Return to oral intake Discharge from the ICU Death
- +4 more secondary outcomes
Study Arms (2)
Interventional
EXPERIMENTALcontrol
OTHERInterventions
Real-time availability in an integrated computer interface (Nutrow) of all clinical and biological information related to nutritional support including recommended, prescribed, and delivered calories and proteins and enteral feed delivery transmitted by the Feedim medical device
Usual use of standard clinical and biological information related to nutritional support as available through the ICU electronic health record (i.e. without any calculated information on recommended, prescribed, or received calories and protein, only information on prescribed products and volumes as collected by and presented in the ICU EHR) In this arm, participants, investigators, and healthcare professionals will be blinded to real-time enteral feed volumes that will be collected by the Feedim medical device and transmitted to the electronic study case report form.
Eligibility Criteria
You may qualify if:
- Age 18 and over.
- French Social Security system registration.
- First stay in ICU
- Admitted to the Lille University Hospital Surgical ICU for at least 3 days.
- Active enteral and/or parenteral nutritional support prescription
- Patient and/or next-of-kin informed about the study and having consented to participation in the study.
You may not qualify if:
- Age under 18
- Burn patient
- Admitted to the ICU with a prior active enteral/parenteral nutritional support before day 3, except trophic nutrition
- Dying patient, not-to-be-resuscitated order, or other treatment limitation decision at ICU admission
- Adult under guardianship
- Department of corrections inmate
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Dim3lead
- Baxter Healthcare Corporationcollaborator
- University Hospital, Lillecollaborator
Study Sites (1)
University Hospital Lille
Lille, 59037, France
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Eric KIPNIS, MD,PhD
University Hospital, Lille
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
March 26, 2024
First Posted
April 2, 2024
Study Start
April 10, 2024
Primary Completion
April 1, 2025
Study Completion
September 1, 2025
Last Updated
August 12, 2024
Record last verified: 2024-08